Abstract
CD44 is the major adhesion molecule for the extracellular matrix components and is implicated in a wide variety of physiological and pathological processes including the regulation of tumor cell growth and metastasis. Our previous studies have shown that CD44 undergoes sequential proteolytic cleavages in the extracellular and transmembrane domains and the cleavage product derived from CD44 intramembranous cleavage acts as a signal transduction molecule. However, the underlying mechanism of the intramembranous cleavage of CD44 remains to be elucidated. In the present study, we report for the first time that CD44 is a substrate of the presenilin (PS)-dependent γ-secretase. We demonstrate that the intramembranous cleavage of CD44 induced by 12-O-tetradecanoylphorbol 13-acetate (TPA) treatment or mechanical scraping is blocked by γ-secretase inhibitors in U251MG cells and that this cleavage is also inhibited in PS-deficient mouse embryonic fibroblasts. Furthermore, we showed that PS1 is redistributed to ruffling areas of the plasma membrane similarly to CD44 after TPA treatment, supporting our biochemical observation that PS1 is involved in the intramembranous cleavage of CD44. Our present findings suggest important implications for understanding CD44-dependent signal transduction and a potential role of PS/γ-secretase activity in the functional regulation of adhesion molecules.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aruffo A, Stamenkovic I, Melnick M, Underhill CB and Seed B . (1990). Cell, 61, 1303–1313.
Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK and Rosenfeld MG . (2002). Cell, 110, 55–67.
Cao X and Sudhof T.C . (2001). Science, 293, 115–120
Culty M, Miyake K, Kincade PW, Sikorski E, Butcher EC, Underhill C and Silorski E . (1990). J. Cell Biol., 111, 2765–2774.
De Strooper B and Annaert W . (2001). Nat. Cell Biol., 3, E221–E225.
De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A and Kopan R . (1999). Nature, 398, 518–522.
De Strooper B, Beullens M, Contreras B, Levesque L, Craessaerts K, Cordell B, Moechars D, Bollen M, Fraser P, George-Hyslop PS and Van Leuven F . (1997). J. Biol. Chem., 272, 3590–3598.
Egeblad M and Werb Z . (2002). Nat. Rev. Cancer, 2, 161–174.
Esler WP and Wolfe MS . (2001). Science, 293, 1449–1454.
Evin G, Cappai R, Li QX, Culvenor JG, Small DH, Beyreuther K and Masters, C.L . (1995). Biochemistry, 34, 14185–14192.
Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H and Herrlich P . (1991). Cell, 65, 13–24.
Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, Serneels L, Umans L, Schrijvers V, Checler F, Vanderstichele H, Baekelandt V, Dressel R, Cupers P, Huylebroeck D, Zwijsen A, Van Leuven F and De Strooper B . (1999). Proc. Natl. Acad. Sci. USA, 96, 11872–11877.
Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L and De Strooper B . (2000). Nat. Cell Biol., 2, 461–462.
Hooper NM, Karran EH, Turner AJ . (1997). Biochem. J., 321, 265–279.
Ito K, Okamoto I, Araki N, Kawano Y, Nakao M, Fujiyama S, Tomita K, Mimori T and Saya H . (1999). Oncogene, 18, 7080–7090.
Kaether C, Lammich S, Edbauer D, Ertl M, Rietdorf J, Capell A, Steiner H and Haass C . (2002). J. Cell Biol., 158, 551–561.
Kawano Y, Okamoto I, Murakami D, Itoh H, Yoshida M, Ueda S and Saya H . (2000). J. Biol. Chem., 275, 29628–29635.
Lee HJ, Jung KM, Huang YZ, Bennett LB, Lee JS, Mei L and Kim TW . (2002). J. Biol. Chem., 277, 6318–6323.
Lesley J and Hyman R . (1998). Front. Biosci., 3, D616–D630.
Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD and Wang K et al. (1995). Science, 269, 973–977.
Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T and Robakis NK . (2002). EMBO J., 21, 1948–1956.
May P, Reddy YK and Herz J . (2002). J. Biol. Chem., 277, 18736–18743.
Ni CY, Murphy MP, Golde TE and Carpenter G . (2001). Science, 294, 2179–2181.
Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM and Mareel M . (2001). J. Cell Sci., 114, 111–118.
Okamoto I, Kawano Y, Matsumoto M, Suga M, Kaibuchi K, Ando M and Saya H . (1999a). J. Biol. Chem., 274, 25525–25534.
Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T, Wong AJ and Saya H . (2001). J. Cell Biol., 155, 755–762.
Okamoto I, Kawano Y, Tsuiki H, Sasaki J, Nakao M, Matsumoto M, Suga M, Ando M, Nakajima M and Saya H . (1999b). Oncogene, 18, 1435–1446.
Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbl S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM and St George-Hyslop PH. (1995). Nature, 376, 775–778.
Sadot E, Simcha I, Shtutman M, Ben-Ze'ev A and Geiger B . (1998). Proc. Natl. Acad. Sci. USA, 95, 15339–15344.
Seiffert D, Bradley JD, Rominger CM, Rominger DH, Yang F, Meredith Jr JE, Wang Q, Roach AH, Thompson LA, Spitz SM, Higaki JN, Prakash SR, Combs AP, Copeland RA, Arneric SP, Hartig PR, Robertson DW, Cordell B, Stern AM, Olson RE and Zaczek R . (2000). J. Biol. Chem., 275, 34086–34091.
Shearman MS, Beher D, Clarke EE, Lewis HD, Harrison T, Hunt P, Nadin A, Smith AL, Stevenson G and Castro JL . (2000). Biochemistry, 39, 8698–8704.
Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM and St George-Hyslop PH . (1995). Nature, 375, 754–760.
Struhl G, Adachi A . (2000). Mol. Cell, 6, 625–636.
Weber GF, Bronson RT, Ilagan J, Cantor H, Schmits R and Mak TW . (2002). Cancer Res., 62, 2281–2286.
Acknowledgements
We are grateful to Dr Yasuo Ihara (University of Tokyo) for providing antibody C4; Dr WG Stetler-Stevenson for providing BB94; and members of the Gene Technology Center in Kumamoto University for their important contributions to the experiments. We wish to thank Yoshimi Fukushima for secretarial assistance. This work was supported by a grant for cancer research from the Ministry of Education, Science and Culture of Japan (HS) and ‘Research for the Future’ program of the Japan Society for the Promotion of Science (HS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murakami, D., Okamoto, I., Nagano, O. et al. Presenilin-dependent γ-secretase activity mediates the intramembranous cleavage of CD44. Oncogene 22, 1511–1516 (2003). https://doi.org/10.1038/sj.onc.1206298
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206298
Keywords
This article is cited by
-
CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?
Clinical & Experimental Metastasis (2023)
-
Presenilin1 inhibits glioblastoma cell invasiveness via promoting Sortilin cleavage
Cell Communication and Signaling (2021)
-
Evaluating nuclear translocation of surface receptors: recommendations arising from analysis of CD44
Histochemistry and Cell Biology (2020)
-
Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation
Oncogene (2019)
-
Stiffness-dependent motility and proliferation uncoupled by deletion of CD44
Scientific Reports (2017)